| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962817 | Vaccine | 2016 | 7 Pages |
Abstract
TIVc was well tolerated and had a safety and reactogenicity profile similar to that of TIVf in healthy 4-17 yearolds (NCT01857206).
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Terry Nolan, Tawee Chotpitayasunondh, Maria Rosario Capeding, Simon Carson, Shelly David Senders, Peter Jaehnig, Richard de Rooij, Richa Chandra,